Translational Neuroscientist and Bioengineer. Assistant Professor, Dept. of Neurological Sciences, Larner College of Medicine at the University of Vermont.
Heartiest congratulations to our postdoc Kathryn Morelli on her new position as Assistant Professor at the Dept of Neurological Sciences at the University of Vermont!!! Please follow @khmorelli for more amazing science!
Expressing an RNA-targeting CRISPR–Cas13d system in #Huntington's disease mouse model striatum selectively reduces mutant HTT mRNA and protein, improves motor coordination, and reduces atrophy
New from @yeo_lab@khmorelli@QianWu666666 @duanwen06 et al.
https://t.co/tYetbxtWJL
UCSD's press release describing our recent work with Leslie Thompson and Wenzhen Duan in demonstrating the reduction of RNA and protein toxicity in preclinical models of Huntington's diseases. https://t.co/UdDTNP087z
Our latest research published with @SpringerNature in @NatureNeuro targeting the expanded CAG repeats in Huntington's IPSC and mouse disease models in collaboration with Leslie Thompson and Wenzhen Duan. Congrats Kathy, Maya and colleagues at my lab.https://t.co/pOt9vonpHj
@elonmusk Then please fix Tesla’s leasing department. I moved and they have refused to send the title to my new state (it’s been 9 months) so now my car which I’m still required to pay for remains unregistered and undriveable……….care about your customers
To identify that loss of RNA binding protein CELF2 leads to dysfunction in the MECP2 pathway. Recognizing that loss of MECP2 is associated with Rett’s syndrome, we explored NMDA antagonists, which are currently in clinical trials for Rett’s, to rescue neuronal dysfunction.
Myotonic dystrophy type 1 (DM1) is the most common form of muscular dystrophy but the molecular basis for neurocognitive defects in DM1 patients is unknown. Excited to share our cover work where we generated 3D cortical organoids from DM1 patients.
https://t.co/f5AxFwi4fG
First author postdoc @khmorelli and team leveraged single-cell RNA-seq, RNA-targeting CRISPR/Cas13d, enhanced CLIP, multi-electrode arrays and integrative analysis to study her 3D cortical organoids. Congrats Kathy and current and past members in @yeo_lab and John Day at Stanford
I was thinking about some of the comments I received on my F32 NIH postdoctoral fellowship application from 6-7 years ago. It’s surprising how frustrated I still get when I think about it. A thread... 1/
@DavidZodda Back in 2018, when Trump fired the Pandemic Preparedness Task Force, he stated his position clearly: "Public health and safety isn't the governmemnt's job".
In an editorial, @hholdenthorp emphasizes that for science to be best equipped to serve people "on demand” —such as developing a #coronavirus vaccine on a rapid timeline — science must be respected and experts allowed to communicate. https://t.co/vvf41KmY0D
We are excited to share that @Invitae has opened a program offering free #genetic testing and post-test counseling to those suspected of having diseases, including #musculardystrophy, to promote early diagnosis and treatment. Learn more from @md_today: https://t.co/rZmD5JPM2z
Our national ambassador Faith Fortenberry learned the true meaning of independence when she was able to swim for three hours thanks to the impact of MDA funding that made new treatments possible! https://t.co/f9KGYGbUIp
MG FAMILIES: Researchers @AlexionPharma are looking for children w/ #myastheniagravis to participate in a Phase 3 study to evaluate whether eculizumab leads to increased muscle strength. See details about this #clinicaltrial here: https://t.co/WGXk6N8hUG
A research team has engineered a therapeutic #protein that enhances the #cancer-killing power of #TCells while avoiding healthy tissue damage in mice and a monkey with #ColonCancer. Read the research from @ScienceTM: https://t.co/Ae25cEYn7D